Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people notice the first effects of Mounjaro within the opening days of their first injection — reduced appetite, a quicker sense of fullness, and sometimes mild nausea. Measurable weight change typically follows over weeks, not hours. Mounjaro (tirzepatide) is a prescription-only medicine; a clinical assessment determines whether it is suitable for you before any treatment begins. Our Mounjaro overview covers the broader picture if you are still weighing your options.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
For many people, yes, something shifts noticeably in the first few days. Mounjaro activates two gut-hormone receptors, GIP and GLP-1, which play a role in signalling fullness and slowing gastric emptying. That slowing is often the first thing people become aware of: meals feel like enough sooner than usual, and the urge to snack between them quietens. Some people also notice mild nausea, particularly in the day or two after the injection.
None of this means weight is falling yet. The early effects are largely physiological, changes in hunger and digestion rather than changes on the scale. The 2.5mg starter dose is deliberately cautious; its main job is letting your system settle, not driving significant weight loss. If you are curious about the typical timeline in more detail, our page on how long it takes to feel the effects of Mounjaro walks through what most people experience week by week. You can read more about what the early weeks involve on our page looking at how long after taking Mounjaro you feel the effects.
It is worth being honest about the variability here. A minority of people feel very little in the first week. Stress, sleep, diet and individual metabolism all influence how noticeable those early signals are. That is not a sign the medicine is not working, it means titration matters.
Most people see the scales move meaningfully somewhere between weeks two and six, with the shift becoming clearer as the dose increases. Mounjaro is titrated in steps (2.5mg, 5mg, 7.5mg and upward) typically at four-week intervals decided by your prescriber. Each step tends to deepen the appetite suppression and, for many, accelerates the weight-loss rate.
The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed 2,539 adults over 72 weeks. At the 15mg maintenance dose, average body-weight reduction reached around 20–21%. That is a cumulative figure built over the full trial period, not something that arrives in the first month. The practical implication is that patience in the early weeks pays off later.
People who plateau briefly after a dose increase, or who feel their progress slow mid-treatment, often find the next titration step shifts things again. This is why the prescriber relationship matters throughout, not just at the start. Our page on how long Mounjaro takes to work goes into more detail on the dose-by-dose trajectory.
Mounjaro reaches its peak plasma concentration roughly 24–72 hours after a subcutaneous injection, according to pharmacokinetic data in the SmPC. In practice, people often report the appetite-suppressing effect is strongest in the two to three days following the injection, with a gradual softening toward the end of the week before the next dose is due.
A consistent injection day helps. Many people tie it to a fixed weekly routine, Sunday evenings, say, or a particular morning before work. The pen itself lives in the fridge, so the easiest anchors tend to be domestic ones. Wherever you keep it, rotating the injection site each week (abdomen, thigh, upper arm) is advised per the prescriber's guidance and the Patient Information Leaflet.
Whether to take it on a specific day relative to meals is a question for your prescriber; timing of meals does not affect absorption the way it does with the oral semaglutide tablet. For a broader look at how duration and effect relate, the page on how long Mounjaro's effects last covers what happens across the dosing week.
Both ends of the spectrum are worth understanding. Feeling little in the first two weeks is not unusual and does not predict poor outcomes. The titration process is designed precisely because individual response varies; a full picture of how the medicine is working for you only emerges over several months.
At the other end, strong nausea or vomiting after an injection can be distressing. These are listed among the common side effects on the NHS tirzepatide medicines page, and they are typically most pronounced after the starting dose or after a dose increase, usually settling within days. Staying well hydrated, eating smaller meals, and avoiding rich or fatty food shortly after injecting can all help. If symptoms are severe or persistent (particularly any strong pain in the abdomen that spreads toward the back) that warrants urgent medical attention, not watchful waiting.
If you have questions about how your treatment is going, the right person to speak to is your prescriber, not a forum. At nume, our prescribers are available for aftercare seven days a week; you can reach us via the contact page. If you are still thinking about whether Mounjaro is right for you, our Mounjaro cost page explains what a private prescription typically involves, and the FAQs cover common questions about the process. When you are ready, you can check your eligibility through a free consultation with one of our GPhC-registered prescribers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.